Clinical trial
Assessment of the Response to the Complete Vaccination Guidelines Against Sars-cov2 in Patients With Inflammatory Bowel Disease Under Inmunosuppressor Treatment
NCT05153850 is registered in ClinicalTrials.gov with Fundación Pública Andaluza para la gestión de la Investigación en Sevilla as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of the Response to the Complete Vaccination Guidelines Against Sars-cov2 in Patients With Inflammatory Bowel Disease Under Inmunosuppressor Treatment
- Lead sponsor
- Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 1, 2022
- Completion date
- September 1, 2022
- Enrollment
- 243 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.